Major owner of AMAG Pharmaceuticals just sold 38,600 shares

Capital Partners Adage, a major owner of AMAG Pharmaceuticals, recently sold 38,600 shares of the company. The sales took place at prices ranging from $23.70 to $24.76 per share, on dates ranging from August 29 to September 03, 2013. Adage still owns 11,513,876 shares of the company. Adage operates out of Boston, MA. Some additional info was provided as follows:

Adage Capital Partners GP, L.L.C., a Delaware limited liability company ("ACPGP"), serves as the general partner of Adage Capital Partners, L.P., a Delaware limited partnership (the "Fund"), and as such has discretion over the portfolio securities beneficially owned by the Fund. Adage Capital Advisors, L.L.C., a Delaware limited liability company ("ACA"), is the managing member of ACPGP and directs ACPGP's operations. Robert Atchinson and Phillip Gross are the managing members of ACPGP and ACA and general partners of the Fund. ACPGP, ACA, Robert Atchinson and Phillip Gross disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein.

The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.

To receive a free e-mail notification whenever AMAG Pharmaceuticals makes a similar move, sign up!

Other recent filings from the company include the following:

Other definitive proxy statements - April 18, 2014

   Auto Refresh